Arabian Post Staff -Dubai The UAE has approved Lipfendra, a once-daily pill designed to sharply reduce harmful cholesterol, becoming the second country after the United States to authorise the first oral treatment targeting the PCSK9 protein. The Emirates Drug Establishment approved the medicine for adults with elevated low-density lipoprotein cholesterol, or LDL-C, including those with heterozygous familial hypercholesterolaemia, an inherited disorder that causes dangerously high cholesterol levels. [...] The article UAE clears first oral PCSK9 cholesterol treatment appeared first on Arabian Post .
